Literature DB >> 2298100

Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.

G Verazin1, W M Riley, J Gregory, C Tautu, J J Prorok, J A Alhadeff.   

Abstract

Total sialic acid (TSA), total protein (TP), TSA normalized to total TP (TSA/TP), and carcinoembryonic antigen levels were determined in 146 consecutive colorectal patients. These results were compared with results from 73 people with nonmalignant gastrointestinal disease, and with results from 96 normal controls. All malignancies were staged according to the Astler-Coller modification of Dukes' classification for colorectal cancer. All blood samples were drawn before surgical therapy. The TSA/TP ratio for colorectal cancer was 13.4 (mg/gm) in contrast to 12.1 (mg/gm) for pathologic controls, and 9.7 (mg/gm) for normal controls. Student's t test showed a P value less than 0.001 for normal controls and a P value less than 0.001 for pathologic controls. The TSA/TP also showed statistical significance in Dukes A, B2, C, and D subgroups when compared with normal controls. There were only four patients with stage C1 carcinoma, thus statistical analysis would be questionable. In contrast, carcinoembryonic antigen levels showed no significant elevations until Dukes C2 tumors were encountered. These preliminary findings suggest that TSA/TP ratio may detect colorectal cancer patients with less tumor burden and be more beneficial as a tumor marker than CEA for monitoring patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298100     DOI: 10.1007/bf02055544

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

2.  Glycosidically bound sialic acid levels as a predictive marker of postoperative adjuvant therapy in gastric cancer.

Authors:  K Ogoshi; Y Kondoh; T Tajima; T Mitomi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Serum total sialic acid in differential diagnostics of jaundice caused by malignant and nonmalignant diseases: a ROC curve analysis.

Authors:  Bogdan Cylwik; Lech Chrostek; Bogdan Zalewski; Andrzej Dabrowski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

4.  Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors.

Authors:  Manjula Shantaram; Anjali Rao; Annaya Rao Aroor; Annaswamy Raja; Suryanrayana Rao; Flama Monteiro
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

5.  Elevated Serum Sialic Acid Levels Predict Prostate Cancer As Well As Bone Metastases.

Authors:  Cong Zhang; Lei Yan; Hongkai Song; Zheng Ma; Dongshan Chen; Feilong Yang; Liang Fang; Zeyan Li; Kui Li; Dawei Li; Nengwang Yu; Hainan Liu; Zhonghua Xu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

6.  Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.

Authors:  Jingjing Shan; Benxing Gu; Liming Shi; Xuanxuan Wang; Wenyuan Ye; Weiwen Zhou; Xiaonan Sun
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.